ArticleClinical cancer research : an official journal of the American Association for Cancer Research2022

Determinants of Response to Talazoparib in Patients with HER2-Negative, Germline BRCA1/2-Mutated Breast Cancer.

Joanne L Blum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.